Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2014 | One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles. | Kao, CH; Wang, JY; Chuang, KH; Chuang, CH; Cheng, TC; Hsieh, YC; Tseng, YL; Chen, BM; Roffler, SR; Cheng, TL | Biomaterials 35(37), 9930-9940 | |||
2014 | PET Imaging of beta-Glucuronidase Activity by an Activity-Based 124I-Trapping Probe for the Personalized Glucuronide Prodrug Targeted Therapy. | Su, YC; Cheng, TC; Leu, YL; Roffler, SR; Wang, JY; Chuang, CH; Kao, CH; Chen, KC; Wang, HE; Cheng, TL | Molecular Cancer Therapeutics 13(12), 2852-2863 | |||
2021 | Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy | Chuang, HH; Zhen, YY; Tsai, YC; Chuang, CH; Huang, MS; Hsiao, M ; Yang, CJ | BIOMEDICINES 9(4), 359 | |||
2016 | Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles. | Hsieh, YC; Cheng, TC; Wang, HE; Li, JJ; Lin, WW; Huang, CC; Chuang, CH; Wang, YT; Wang, JY; Roffler, SR; Chuang, KH; Cheng, TL | Scientific reports 6, 39119 |